Explore how artificial intelligence is changing cancer care and what it means for the future of precision oncology.

Patients deserve to benefit from the power of their data, but they also deserve to know, to choose, and to trust.

At the heart of equitable healthcare lies a critical truth: representation matters.  BlackDoctor.org spoke with Dr. Adrelia ...

The company refused the FDA’s request and will continue shipping its therapy, Elevidys, to Duchenne patients who can still ...

Last week, antivaxxer Toby Rogers published two very long screeds attacking the EBM paradigm. Cleverly, echoed some of our ...

While Sarepta has now consented to the FDA’s request to stop selling Elevidys, the company’s brief standoff with the agency ...

Regulators plan to integrate ibogaine treatment into Colorado’s psychedelic healing industry. Still, the drug faces an uncertain future.

ICMR to hold workshop on clinical trials from Sept 15- 19 in Pune to empower ethical excellence in clinical research: Shardul Nautiyal, Mumbai Monday, July 21, 2025, 08:00 Hrs [IS ...

The demand follows alarming new regulatory agency warnings from Australia and Germany about atomoxetine, a“non-stimulant” ...

The Mayo Clinic Center for Individualized Medicine's Tapestry 2.0 research study explores how interactions between people's genes and their environments affect human disease.

CCHR urges urgent reforms to ensure families are fully informed about life-threatening side effects of ADHD psychotropics and ...

Sarepta Therapeutics’ share price has fallen again following the death of a third patient dosed with its gene therapy treatment.